PDS Biotechnology Corporation
PDSB
$0.78
$0.010.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.56M | 3.41M | 3.27M | 2.83M | 3.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.14M | 7.62M | 9.11M | 7.36M | 10.18M |
| Operating Income | -8.14M | -7.62M | -9.11M | -7.36M | -10.18M |
| Income Before Tax | -9.01M | -9.43M | -9.66M | -7.95M | -10.73M |
| Income Tax Expenses | -- | -- | -1.17M | 0.00 | -- |
| Earnings from Continuing Operations | -9.01M | -9.43M | -8.49M | -7.95M | -10.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.01M | -9.43M | -8.49M | -7.95M | -10.73M |
| EBIT | -8.14M | -7.62M | -9.11M | -7.36M | -10.18M |
| EBITDA | -8.13M | -7.61M | -9.09M | -7.35M | -10.16M |
| EPS Basic | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 |
| Normalized Basic EPS | -0.12 | -0.13 | -0.15 | -0.13 | -0.18 |
| EPS Diluted | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 |
| Normalized Diluted EPS | -0.12 | -0.13 | -0.15 | -0.13 | -0.18 |
| Average Basic Shares Outstanding | 46.87M | 45.90M | 40.52M | 37.49M | 36.81M |
| Average Diluted Shares Outstanding | 46.87M | 45.90M | 40.52M | 37.49M | 36.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |